Fennec Pharmaceuticals Inc. Share Price Toronto S.E.
Equities
FRX
CA31447P1009
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 CAD | -0.55% |
|
+12.62% | -39.97% |
Sales 2024 * | 62.94M 86.08M 5.26B | Sales 2025 * | 67.21M 91.92M 5.62B | Capitalization | 182M 249M 15.2B |
---|---|---|---|---|---|
Net income 2024 * | 14M 19.15M 1.17B | Net income 2025 * | 16M 21.88M 1.34B | EV / Sales 2024 * | 2.89 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.3
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.15% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | -0.55% | ||
1 week | +12.62% | ||
Current month | +8.08% | ||
1 month | -2.57% | ||
3 months | -33.91% | ||
6 months | -36.01% | ||
Current year | -39.97% |
![Extreme 8.66](/images/extremecours_fleche.png)
![Extreme 7.8](/images/extremecours_fleche.png)
![Extreme 7.8](/images/extremecours_fleche.png)
![Extreme 7.8](/images/extremecours_fleche.png)
![Extreme 4.95](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/09/07 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/09/07 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25/11/25 |
Khalid Islam
CHM | Chairman | 67 | 25/14/25 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/09/07 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 9.1 | -0.55% | 1,202 |
16/24/16 | 9.15 | +0.99% | 600 |
15/24/15 | 9.06 | +4.02% | 8,050 |
12/24/12 | 8.71 | -2.13% | 600 |
11/24/11 | 8.9 | +10.15% | 4,701 |
Delayed Quote Toronto S.E., July 18, 2024 at 01:29 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 117B | |
+22.65% | 27.52B | |
-18.07% | 20.87B | |
-13.99% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- FENC Stock
- FRX Stock